Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [1] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Reinhard E. Friedrich
    Sylva Bartel-Friedrich
    Hartmut Lobeck
    Gerald Niedobitek
    Hartmut Arps
    Medical Microbiology and Immunology, 2003, 192 : 141 - 144
  • [2] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Friedrich, RE
    Bartel-Friedrich, S
    Lobeck, H
    Niedobitek, G
    Arps, H
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 192 (03) : 141 - 144
  • [3] SUPERINFECTION OF EPITHELIAL NASOPHARYNGEAL CARCINOMA CELLS WITH EPSTEIN-BARR VIRUS
    GLASER, R
    THE, GD
    LENOIR, G
    HO, JHC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (03) : 960 - 963
  • [4] Epstein-Barr virus and nasopharyngeal carcinoma
    Lawrence SYoung
    Christopher WDawson
    Chinese Journal of Cancer, 2014, 33 (12) : 581 - 590
  • [5] THE EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA
    TARR, KL
    GLASER, R
    MICROBIAL PATHOGENESIS, 1989, 7 (01) : 11 - 14
  • [6] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [7] Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma
    Yap, Yoke-Yeow
    Hassan, Shahid
    Chan, Melissa
    Choo, Pua Kin
    Ravichandran, Manickam
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (06) : 986 - 991
  • [9] Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
    Chan, K. C. Allen
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 598 - 603
  • [10] Detection of Epstein-Barr virus in nasopharyngeal carcinoma
    Hasegawa, M
    Kobayashi, R
    Okayasu, I
    Hirai, H
    E.R.S. & I.S.I.A.N. MEETING '98, 1998, : 323 - 326